TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 61.50
+0.10 (0.16%)
Nov 10, 2026, 1:30 PM CST
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 2.36 billion as of November 9, 2026. It is the 27,315th most valuable company in the world and the 1,515th biggest in Taiwan. Its market cap has increased by 13.05% in one year.
Market Cap
2.36B
Enterprise Value
1.95B
Revenue
1.53B
Global Rank
Country Rank
#1,515 Taiwan
PE Ratio
11.28
ChartMarket Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has increased from 1.96B to 2.36B, an increase of 20.35%. That is a compound annual growth rate of 1.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 2.36B | 5.13% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 4.50B |
| Panion & Bf Biotech | 4.23B |
| Yoda Pharmaceuticals | 3.87B |
| Orient EuroPharma | 3.65B |
| Easywell Biomedicals | 3.10B |
| Maywufa Company | 2.76B |
| Allied Biotech | 2.60B |
| Merdury Biopharmaceutical | 2.33B |